Clinical Trial Update: VNP40101M in Treating Patients With Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of VNP40101M in adults with advanced or metastatic cancer has completed. The sponsor is Vion Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer
• Unspecified Adult Solid Tumor

Drugs mentioned

• VNP40101M

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: COMPLETED